2015. Haemophilus influenzae Type b/Polyribosylribitol Phosphate-Tetanus (Hib/PRP-T) Vaccine Safety, Phase I Study. International Journal of Integrated Health Sciences. 3, 2 (Sep. 2015), 55–59. DOI:https://doi.org/10.15850/ijihs.v3n2.584.